Perinatal use of triptans and other drugs for migraine-A nationwide drug utilization study.
<h4>Objective</h4>To characterize nationwide utilization patterns of migraine pharmacotherapy before, during, and after pregnancy in women with triptan use.<h4>Methods</h4>Population-based data were obtained by linking the Medical Birth Registry of Norway and the Norwegian Pr...
Guardado en:
Autores principales: | Fatima Tauqeer, Mollie Wood, Sarah Hjorth, Angela Lupattelli, Hedvig Nordeng |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fa7e26a8db09438bb141ac5c62683302 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Dihydroergotamine and triptan use to treat migraine during pregnancy and the risk of adverse pregnancy outcomes
por: Anick Bérard, et al.
Publicado: (2021) -
Utility and Safety of Perampanel in Pediatric FIRES and Other Drug-Resistant Epilepsies
por: Guo Yong Lim BSc(Pharm.)(Hons.), et al.
Publicado: (2021) -
Prescribing errors involving antineoplastics and others drug centre of preparation of injectable drugs
por: Luciana SANTOS, et al.
Publicado: (2020) -
The British journal of addiction (to alcohol and other drugs)
Publicado: (1979) -
Clinical utility of implantable neurostimulation devices in the treatment of chronic migraine
por: Freeman JA, et al.
Publicado: (2013)